This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01669/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01669/identifier/kegg-compound/
n14http://linked.opendata.cz/resource/mesh/concept/
n15http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB01669/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/resource/drugbank/drug/DB01669/identifier/wikipedia/

Statements

Subject Item
n2:DB01669
rdf:type
n5:Drug
n5:description
Pristinamycin IIA is a macrolide antibiotic. It is a member of the streptogramin A group of antibiotics and one component of pristinamycin (the other being pristinamycin IA). It is produced by Streptomyces graminofaciens and other bacteria.
n5:generalReferences
# "US Biological":http://www.usbio.net/item/O8070-50
n5:group
experimental
n5:indication
For the treatment of bacterial infections.
owl:sameAs
n4:DB01669 n15:DB01669
dcterms:title
Virginiamycin M1
adms:identifier
n8:C11299 n9:VIR n10:DB01669 n11:Pristinamycin_IIA
n5:mechanismOfAction
Virginiamycin M1 is a macrocyclic lactone antibiotic that acts syngeristically with the structurally unrelated cyclic depsipeptides more commonly known as the virginiamycins B (ostreogrycin B or streptogramin B) and S to inhibit peptide elongation. This is achieved by blocking formation of a peptide bond between the growing peptide chain (peptidyl-tRNA) linked to the 50S ribosome and aminoacyl-tRNA. Virginiamycin M1 has proven to be highly active against Gram positive bacteria, particularly methicillin-resistant S. aureus.
n5:synonym
Streptogramin A Ostreogrycin A Mikamycin A Pristinamycin IIA
n13:hasConcept
n14:M0374398
n5:IUPAC-Name
n6:271B6227-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B622D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B622C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6229-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B622A-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B622B-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B6225-363D-11E5-9242-09173F13E4C5 n6:271B623D-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B6223-363D-11E5-9242-09173F13E4C5 n6:271B6226-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B6224-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6233-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6234-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B622E-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B622F-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B6231-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6230-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B6232-363D-11E5-9242-09173F13E4C5
n5:affectedOrganism
Bacteria
n5:casRegistryNumber
21411-53-0
n5:category
n5:Bioavailability
n6:271B6239-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B623B-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B623C-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B6238-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B6237-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B623A-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6228-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B6235-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B6236-363D-11E5-9242-09173F13E4C5